Semler Scientific (NASDAQ:SMLR - Get Free Report) was upgraded by Maxim Group to a "strong-buy" rating in a report released on Wednesday, Marketbeat Ratings reports. The firm currently has a $95.00 price target on the stock. Maxim Group's price target would suggest a potential upside of 112.36% from the company's current price.
Several other research firms have also recently weighed in on SMLR. Benchmark assumed coverage on Semler Scientific in a report on Tuesday. They set a "buy" rating and a $101.00 price target on the stock. Wall Street Zen downgraded Semler Scientific from a "buy" rating to a "sell" rating in a report on Thursday, May 22nd.
Read Our Latest Report on SMLR
Semler Scientific Price Performance
Semler Scientific stock traded down $1.23 during midday trading on Wednesday, reaching $44.74. The company's stock had a trading volume of 645,339 shares, compared to its average volume of 566,825. Semler Scientific has a 52 week low of $21.77 and a 52 week high of $81.56. The company has a current ratio of 0.52, a quick ratio of 0.51 and a debt-to-equity ratio of 0.59. The business has a 50-day moving average price of $37.29 and a 200-day moving average price of $42.24. The stock has a market cap of $612.44 million, a PE ratio of -17.07 and a beta of 1.39.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last released its earnings results on Tuesday, May 13th. The company reported ($0.76) earnings per share (EPS) for the quarter. The business had revenue of $8.84 million during the quarter. Semler Scientific had a negative net margin of 60.69% and a positive return on equity of 19.75%.
Institutional Trading of Semler Scientific
Institutional investors and hedge funds have recently modified their holdings of the business. BNP Paribas Financial Markets bought a new position in shares of Semler Scientific during the 4th quarter valued at about $30,000. Jones Financial Companies Lllp bought a new position in Semler Scientific during the 4th quarter worth approximately $34,000. Larson Financial Group LLC bought a new position in Semler Scientific during the 4th quarter worth approximately $38,000. NewEdge Advisors LLC grew its position in Semler Scientific by 318.3% during the 4th quarter. NewEdge Advisors LLC now owns 732 shares of the company's stock worth $40,000 after acquiring an additional 557 shares during the last quarter. Finally, Summit Securities Group LLC purchased a new stake in Semler Scientific in the 1st quarter worth approximately $32,000. Hedge funds and other institutional investors own 49.37% of the company's stock.
Semler Scientific Company Profile
(
Get Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
See Also
Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
